Welcome to LookChem.com Sign In|Join Free

CAS

  • or

39657-48-2

Post Buying Request

39657-48-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

39657-48-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 39657-48-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,9,6,5 and 7 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 39657-48:
(7*3)+(6*9)+(5*6)+(4*5)+(3*7)+(2*4)+(1*8)=162
162 % 10 = 2
So 39657-48-2 is a valid CAS Registry Number.

39657-48-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-acetoxy-3,5-dimethoxycinnamic acid chloride

1.2 Other means of identification

Product number -
Other names 4-acetoxy-3,5-dimethoxycinnamoyl chloride

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:39657-48-2 SDS

39657-48-2Relevant articles and documents

Research on Crystal Structure and Fungicidal Activity of the Amide Derivatives Based on the Natural Products Sinapic Acid and Mycophenolic Acid

Bazhanau, Dzmitry,Chen, Zhanfang,Chu, Pengfei,Fang, Hongbin,Hua, Xuewen,Liu, Wenrui,Liu, Yi,Ru, Jing,Wang, Bingxiang,Xue, Chenmeng,Yuan, Man,Zhu, Xiaohe

, (2022/01/19)

Structural optimization based on natural products is an important and effective way to discover new green pesticides. Here, two series of amide derivatives based on sinapic acid and mycophenolic acid were designed in combination with the fungicidal natura

DERIVATIVES OF THE SINAPINIC ACID

-

Paragraph 0094; 0095; 0096; 0097, (2016/01/10)

The object of the present invention is a compound of general formula (I) as well as to its pharmaceutically acceptable salt, and to the use of this compound for cosmetic and pharmaceutical applications.

A newly synthesized sinapic acid derivative inhibits endothelial activation in vitro and in vivos

Zeng, Xiaoyun,Zheng, Jinhong,Fu, Chenglai,Su, Hang,Sun, Xiaoli,Zhang, Xuesi,Hou, Yingjian,Zhu, Yi

, p. 1099 - 1108 (2013/06/27)

Inhibition of oxidative stress and inflammation in vascular endothelial cells (ECs) may represent a new therapeutic strategy against endothelial activation. Sinapic acid (SA), a phenylpropanoid compound, is found in natural herbs and high-bran cereals and has moderate antioxidant activity. We aimed to develop new SA agents with the properties of antioxidation and blocking EC activation for possible therapy of cardiovascular disease. We designed and synthesized 10 SA derivatives according to their chemical structures. Preliminary screening of the compounds involved scavenging hydroxyl radicals and 2,2-diphenyl-1- picrylhydrazyl (DPPH×), croton oil-induced ear edema in mice, and analysis of the mRNA expression of adhesion molecules in ECs. 1- Acetyl-sinapic acyl-4-(39-chlorine-)benzylpiperazine (SA9) had the strongest antioxidant and anti-inflammatory activities both in vitro and in vivo. Thus, the effect of SA9 was further studied. SA9 inhibited tumor necrosis factor a-induced upregulation of adhesion molecules in ECs at both mRNA and protein levels, as well as the consequent monocyte adhesion to ECs. In vivo, result of face-toface immunostaining showed that SA9 reduced lipopolysaccharideinduced expression of intercellular adhesion molecule-1 in mouse aortic intima. To study the molecular mechanism, results from luciferase assay, nuclear translocation of NF-kB, and Western blot indicated that the mechanism of the anti-inflammatory effects of SA9 might be suppression of intracellular generation of ROS and inhibition of NF-kB activation in ECs. SA9 is a prototype of a novel class of antioxidant with anti-inflammatory effects in ECs. It may represent a new therapeutic approach for preventing endothelial activation in cardiovascular disorders.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 39657-48-2